The short answer is this: retatrutide looks promising for body composition, but current research does not prove that it directly builds muscle or fully prevents muscle loss
At Centra Internal Medicine, we help you manage these symptoms, and most patients find that they improve as the body adjusts to the medication
Plasma homocysteine as a risk factor for vascular disease
Through the provision of antioxidants, glutathione IV therapy can be used to restore cellular homeostasis
1, 3 Segmental lentigines have also been documented
However, recent research has raised questions about whether some GLP-1 medications, especially semaglutide, may be associated with a higher risk of a rare but serious eye condition called NAION